Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Delta Investment Management LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,934 shares of the medical research company’s stock after selling 551 shares during the period. Delta Investment […]
DiNuzzo Private Wealth Inc. bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,291 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other institutional […]
Cross Staff Investments Inc reduced its holdings in shares of AT&T Inc. (NYSE:T – Free Report) by 4.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,533 shares of the technology company’s stock after selling 680 shares during the period. Cross Staff […]
Eagle Ridge Investment Management decreased its stake in Visa Inc. (NYSE:V – Free Report) by 1.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 75,104 shares of the credit-card processor’s stock after selling 1,377 shares during the quarter. Visa makes up 1.9% of Eagle […]
Golden State Equity Partners grew its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 134.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,493 shares of the biopharmaceutical company’s stock after purchasing an additional 14,607 shares during the quarter. Golden […]
Israel Discount Bank of New York trimmed its stake in shares of BlackRock, Inc. (NYSE:BLK – Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 429 shares of the asset manager’s stock after selling 28 shares during the quarter. Israel […]
New York State Common Retirement Fund lessened its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 7.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,528,539 shares of the company’s stock after selling 207,477 shares during the quarter. AbbVie makes up 0.5% of […]
New York Life Investment Management LLC boosted its holdings in shares of Uber Technologies, Inc. (NYSE:UBER – Free Report) by 3,577.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 293,213 shares of the ride-sharing company’s stock after buying an additional 285,239 shares during the […]
Guyasuta Investment Advisors Inc. trimmed its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 31,256 shares of the company’s stock after selling 1,255 shares during the quarter. Guyasuta Investment Advisors Inc.’s holdings in AbbVie were worth […]
John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […]
Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]